Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV002461704 | SCV002756649 | likely pathogenic | not provided | 2022-11-09 | criteria provided, single submitter | clinical testing | Frameshift variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss of function is a known mechanism of disease; Not observed at significant frequency in large population cohorts (gnomAD); Has not been previously published as pathogenic or benign to our knowledge |
Ambry Genetics | RCV004990778 | SCV005581163 | pathogenic | Cardiovascular phenotype | 2024-12-03 | criteria provided, single submitter | clinical testing | The c.34dupC pathogenic mutation, located in coding exon 1 of the FKBP14 gene, results from a duplication of C at nucleotide position 34, causing a translational frameshift with a predicted alternate stop codon (p.L12Pfs*13). This variant is considered to be rare based on population cohorts in the Genome Aggregation Database (gnomAD). This alteration is expected to result in loss of function by premature protein truncation or nonsense-mediated mRNA decay. As such, this alteration is interpreted as a disease-causing mutation. |